Tag: transfusion-dependent beta-thalassemia
Why CRISPR is Becoming a Standout Winner
CRISPR Therapeutics could be a standout winner this year, we said on April 13.
We also noted, “Cantor Fitzgerald initiated coverage with an outperform rating,...